Unlock AI-driven, actionable R&D insights for your next breakthrough.

Polyvinyl Pyrrolidone Granules: Comprehensive Analysis Of Formulation, Processing, And Industrial Applications

APR 20, 202660 MINS READ

Want An AI Powered Material Expert?
Here's PatSnap Eureka Materials!
Polyvinyl pyrrolidone granules represent a critical pharmaceutical and industrial excipient form, engineered to optimize handling, dispersibility, and functional performance across diverse applications. These granular formulations address fundamental challenges in powder processing—including dust formation, flowability limitations, and dissolution kinetics—while maintaining the inherent biocompatibility and binding efficacy of PVP polymers. Through advanced granulation technologies such as extrusion, spray drying, and wet granulation with controlled particle size distribution, polyvinyl pyrrolidone granules enable precise dosage formulation, enhanced stability, and improved manufacturing efficiency in pharmaceutical tableting, beverage clarification, agrochemical delivery, and controlled-release systems.
Want to know more material grades? Try PatSnap Eureka Material.

Molecular Structure And Physicochemical Properties Of Polyvinyl Pyrrolidone In Granular Form

Polyvinyl pyrrolidone (PVP), chemically designated as poly(1-vinyl-2-pyrrolidinone), constitutes a synthetic water-soluble polymer characterized by repeating N-vinyl-2-pyrrolidinone units 911. The polymer exhibits molecular weights ranging from 2,500 to 3,000,000 Daltons, with commercial grades classified by K-values (K-12, K-15, K-17, K-25, K-30, K-60, K-90, K-120) that correlate directly with viscosity in aqueous solution relative to water 911. The K-value, calculated via Fikentscher's method, serves as a molecular weight indicator: K-30 corresponds to approximately 50,000 Daltons, while K-90 represents approximately 360,000 Daltons 69. Glass transition temperatures range from 130°C to 175°C depending on molecular weight, with higher K-values exhibiting elevated Tg due to increased chain entanglement 1620.

When formulated as granules, PVP retains its exceptional solubility profile—readily dissolving in water, alcohols (methanol, ethanol), ketones, glacial acetic acid, chlorinated hydrocarbons, and phenolic compounds, while remaining insoluble in acetone, diethyl ether, and aliphatic hydrocarbons 1416. The hygroscopic nature of PVP necessitates controlled moisture environments during granule storage, as atmospheric exposure can gradually reduce K-values through hydrolytic or oxidative degradation 18. Crosslinked variants (crospovidone, PVPP) with molecular weights exceeding 1,000,000 Daltons exhibit swelling rather than dissolution behavior, making them suitable for disintegrant applications in tablet formulations 911.

The amphiphilic character of PVP—combining hydrophilic pyrrolidone rings with hydrophobic backbone segments—enables complexation with polyphenolic compounds, metal ions, and anionic polymers 23. This property underpins applications in beverage clarification, where PVPP granules selectively adsorb tannins and anthocyanogens without affecting flavor profiles 3. Thermal stability studies via thermogravimetric analysis (TGA) indicate decomposition onset at approximately 350°C under inert atmosphere, though prolonged exposure to temperatures above 100°C can induce chain scission and K-value reduction 1018.

Granulation Technologies And Particle Engineering For Polyvinyl Pyrrolidone

Extrusion-Based Granulation Methods

Extrusion represents a primary method for producing low-dusting, water-dispersible polyvinyl pyrrolidone granules, particularly for crosslinked PVPP used in beverage clarification 13. The process involves forming a dough by mixing PVPP powder with water (typically 20-40% moisture content), extruding the mixture through a die plate with orifice diameters ranging from 0.5 to 3.0 mm, and subsequently drying the extrudate at 50-80°C to residual moisture below 5% 13. Die plate geometry critically influences granule morphology: circular orifices yield cylindrical granules that fragment into spheroids during drying, while multi-hole configurations enable higher throughput 3.

The extrusion method produces granules with particle size distributions typically between 100-800 μm, with minimal fines (<40 μm) generation—a key advantage for reducing workplace dust exposure and improving handling safety 13. Drying conditions must be optimized to prevent surface case-hardening, which can impair subsequent water dispersibility; fluidized bed drying at 60-70°C with controlled air velocity (0.5-1.5 m/s) provides uniform moisture removal while maintaining granule integrity 1. The resulting granules exhibit bulk densities of 0.4-0.6 g/cm³ and angle of repose values below 35°, indicating excellent flowability for automated dosing systems 3.

Spray Drying And Powder Engineering

Spray drying of aqueous PVP solutions (5-40% w/w concentration) using two-fluid nozzle atomizers generates fine granular powders with at least 90% of particles below 35 μm diameter and average particle sizes under 20 μm 12. This technique is particularly suited for producing pharmaceutical-grade PVP binders with enhanced surface area and rapid dissolution kinetics 12. Inlet air temperatures of 140-180°C and outlet temperatures of 70-90°C prevent thermal degradation while achieving residual moisture content below 3% 12.

The spray-dried morphology—characterized by hollow spherical particles with wrinkled surfaces—provides superior compressibility in direct compression tableting compared to conventional PVP powders 12. Particle size distribution can be modulated by adjusting atomization pressure (2-6 bar), feed rate (50-200 mL/min), and nozzle diameter (0.5-2.0 mm) 12. For applications requiring coarser granules (200-600 μm), spray granulation in fluidized beds combines atomization with agglomeration, yielding dense spherical granules with improved flow properties and reduced electrostatic charging 8.

Wet Granulation With Binder Systems

Wet granulation incorporating PVP as both active ingredient and binder utilizes high-shear mixers or fluid-bed granulators to agglomerate primary particles into 200-1000 μm granules 413. A representative formulation combines the active pharmaceutical ingredient (API) with starch (10-40% w/w), lactose (30-60% w/w), and PVP solution (5-15% w/w, typically K-30 grade) as granulating fluid 45. The liquid-to-solid ratio (0.2-0.4 mL/g) and impeller speed (200-600 rpm in high-shear mixers) govern granule size distribution and porosity 4.

Following granulation, wet granules undergo drying at 50-60°C to 2-5% residual moisture, then sizing through 16-20 mesh sieves (850-1180 μm openings) to achieve uniform particle size 13. Addition of disintegrants (sodium starch glycolate 2-10% w/w, crospovidone 2-5% w/w) and lubricants (magnesium stearate 0.5-2% w/w, talc 1-3% w/w) post-granulation optimizes tablet compression characteristics 913. This approach yields granules with bulk densities of 0.5-0.7 g/cm³, Carr's index below 15% (indicating excellent flowability), and tablet hardness values of 60-120 N at 10 kN compression force 413.

Formulation Strategies For Enhanced Granule Performance

Slow-Release Granule Design With Polyacid Complexation

Innovative slow-release granule systems exploit polyelectrolyte complexation between PVP and enteric polyacids to modulate drug dissolution kinetics 2. The technology involves coating quick-release granules—comprising API, PVP K-30 (10-25% w/w), and disintegrant—with enteric polymers such as Eudragit L100 (methacrylic acid-methyl methacrylate copolymer, 5-20% coating weight gain) 2. During coating, PVP concentrated at the granule surface forms interpolymer complexes with carboxylic acid groups of the enteric polymer, creating a pH-responsive diffusion barrier 2.

This complexation mechanism provides dual advantages: (1) gastric resistance due to enteric polymer insolubility at pH <5.5, and (2) sustained release in intestinal fluid (pH 6.8-7.4) as the complex gradually dissociates, allowing controlled PVP erosion and API diffusion 2. In vitro dissolution studies demonstrate <10% release at 2 hours in 0.1 N HCl, followed by linear release over 8-12 hours in phosphate buffer pH 6.8, achieving zero-order kinetics (R² >0.98) 2. Bioavailability studies in beagle dogs show 1.5-2.0 fold increase in AUC₀₋₂₄ compared to immediate-release formulations, with reduced Cmax fluctuations (coefficient of variation <20%) 2.

Agrochemical Granule Formulation With Polyalkoxylate Synergy

Agrochemical granules incorporating PVP (2-8% w/w) with nonionic polyalkoxylates (3-10% w/w), anionic dispersants (20-40% w/w such as lignosulfonates or naphthalene sulfonates), and water-soluble sugars (5-15% w/w) exhibit superior wetting, dispersion, and suspension stability for pesticide delivery 8. The polyalkoxylate component—typically ethylene oxide-propylene oxide block copolymers with HLB values of 10-14—provides steric stabilization of pesticide particles, while PVP acts as a protective colloid preventing Ostwald ripening 8.

Granulation via pan granulation or extrusion-spheronization produces 0.5-2.0 mm granules with particle size distributions meeting FAO specifications (d₅₀ = 0.8-1.2 mm, <5% fines <0.25 mm) 8. Wettability testing shows complete dispersion within 60 seconds in hard water (342 ppm CaCO₃ equivalent), compared to 180-300 seconds for formulations lacking PVP 8. Suspension stability, quantified by Turbiscan analysis, demonstrates <10% sedimentation after 24 hours at 25°C, ensuring uniform spray application and reduced nozzle clogging 8. Field efficacy trials with triazine herbicides formulated as PVP-containing granules show 15-25% improved weed control compared to wettable powder formulations, attributed to enhanced foliar adhesion and rainfastness 58.

Redispersible Polymer Granules For Pharmaceutical Binding

Redispersible polymer granules composed of polyvinyl acetate (10-95% w/w) and N-vinylpyrrolidone copolymers (5-90% w/w), optionally including water-soluble plasticizers (polyethylene glycol 400-6000, 5-20% w/w) and anti-caking agents (colloidal silica, 1-5% w/w), function as high-performance tablet binders 17. These granules are produced by spray-drying aqueous polymer dispersions (30-50% solids) at inlet temperatures of 120-160°C, yielding free-flowing powders with particle sizes of 50-300 μm 17.

Upon aqueous granulation, the polymer particles redisperse and coalesce, forming continuous binder films around API particles at concentrations as low as 3-8% w/w—significantly lower than conventional PVP solutions (10-20% w/w) required for equivalent binding 17. Tablet mechanical strength, measured by diametral crushing force, reaches 80-150 N at 5% binder content, compared to 40-70 N for PVP K-30 alone 17. Critically, disintegration times remain comparable (3-8 minutes in water at 37°C) despite higher mechanical strength, as the vinyl acetate component provides plasticity without excessive swelling 17. Dissolution profiles of model APIs (acetaminophen, ibuprofen) from tablets prepared with redispersible granules show >85% release within 30 minutes, meeting USP specifications for immediate-release formulations 17.

Applications Of Polyvinyl Pyrrolidone Granules Across Industries

Pharmaceutical Tableting And Controlled-Release Systems

Polyvinyl pyrrolidone granules serve as multifunctional excipients in solid oral dosage forms, functioning simultaneously as binders, disintegrants (crosslinked grades), and matrix-forming agents for controlled release 91113. In direct compression tableting, PVP K-30 granules (0.5-5% w/w) provide sufficient cohesion to form tablets with hardness values of 50-100 N without requiring wet granulation, reducing processing time by 40-60% and energy consumption by 30-50% compared to traditional wet granulation 1217.

For sustained-release applications, hydrophilic matrix tablets incorporating PVP K-90 granules (20-40% w/w) exhibit diffusion-controlled release following Higuchi kinetics, with release exponents (n) of 0.45-0.55 indicating Fickian diffusion 611. The gel layer thickness, measured by texture analysis, increases linearly with time (0.5-2.0 mm after 6 hours), creating a diffusional barrier that modulates API release over 8-24 hours 6. Comparative studies demonstrate that PVP-based matrices provide more reproducible release profiles (RSD <8% between batches) than hydroxypropyl methylcellulose (HPMC) matrices (RSD 12-18%), attributed to PVP's superior batch-to-batch consistency in molecular weight and viscosity 611.

Crospovidone granules (2-5% w/w), with molecular weights exceeding 1,000,000 Daltons, function as superdisintegrants by rapidly imbibing water (swelling capacity 50-150% w/w within 30 seconds) and generating capillary forces that fragment tablets 911. Disintegration times for tablets containing crospovidone granules average 45-120 seconds in water at 37°C, compared to 180-360 seconds for tablets with starch-based disintegrants 9. This rapid disintegration translates to faster onset of action, particularly critical for analgesics and antiemetics where therapeutic effect within 15-30 minutes is desired 11.

Beverage Clarification And Polyphenol Removal

Crosslinked polyvinyl pyrrolidone (PVPP) granules constitute the industry standard for removing polyphenolic compounds from beer, wine, fruit juices, and tea beverages 13. The clarification mechanism involves hydrogen bonding between pyrrolidone carbonyl groups and phenolic hydroxyl groups, with binding capacities of 80-150 mg gallic acid equivalents per gram PVPP 3. Particle size critically influences performance: granules with d₅₀ of 40-80 μm provide optimal balance between adsorption kinetics (surface area ~15-25 m²/g) and filterability, achieving >90% polyphenol removal within 30-60 minutes contact time at dosages of 20-100 g/hL 3.

In brewing applications, PVPP granules selectively adsorb proanthocyanidins and catechins responsible for chill haze formation, without affecting flavor-active compounds such as iso-alpha acids (bitterness) or esters (fruity notes) 3. Pilot-scale trials demonstrate that beer treated with 50 g/hL PVPP granules exhibits haze values <0.5 EBC units after 90 days storage at 0°C, compared to 3-8 EBC units for untreated controls 3. The granules can be regenerated by washing with 0.5-1.0% sodium hydroxide solution at 60-80°C, recovering >95% of initial binding capacity for up to 10 cycles, providing economic advantages over single-use clarifying agents 13.

Wine clarification with PVPP granules (10-50 g/hL) reduces browning potential by removing oxidizable phenolics, extending shelf life by 6-12 months as measured by color stability (ΔE <3 after 6 months at 25°C) 3. The low-dusting granular form minimizes occupational exposure risks compared to fine PVPP powders, with airborne particle concentrations <0.5 mg/m³ during handling versus 5-15 mg/m³ for conventional powders 13.

Cosmetic

OrgApplication ScenariosProduct/ProjectTechnical Outcomes
BASF SEBeverage clarification for beer and wine, removing polyphenolic compounds with >90% efficiency within 30-60 minutes, and pharmaceutical excipient applications requiring dust-free handling and automated dosing systems.Kollidon (PVP Granules)Extrusion-based granulation produces low-dusting water-dispersible granules with particle size 100-800μm, bulk density 0.4-0.6 g/cm³, and angle of repose below 35°, ensuring excellent flowability and reduced workplace dust exposure.
TEYSAN PHARMACEUTICALS CO. LTD.Controlled-release pharmaceutical tablets requiring gastric resistance and sustained intestinal drug delivery, particularly for medications requiring reduced dosing frequency and minimized plasma concentration fluctuations.Slow-Release Granule SystemPolyelectrolyte complexation between PVP K-30 and enteric polymers (Eudragit L100) achieves sustained release over 8-12 hours with zero-order kinetics (R²>0.98), and 1.5-2.0 fold increase in AUC compared to immediate-release formulations.
BASF SEPesticide and herbicide delivery systems requiring enhanced wetting, suspension stability, foliar adhesion, and rainfastness for uniform spray application in agricultural field operations.Agrochemical Granule FormulationPVP-containing granules (2-8% w/w) with polyalkoxylates achieve complete dispersion within 60 seconds in hard water, <10% sedimentation after 24 hours, and 15-25% improved weed control efficacy compared to wettable powder formulations.
BASF AKTIENGESELLSCHAFTDirect compression tableting and pharmaceutical wet granulation processes requiring high binding efficiency, reduced processing time (40-60% reduction), and energy savings (30-50% reduction) with maintained immediate-release dissolution profiles.Redispersible Polymer Granules (Vinyl Acetate-PVP Copolymer)Spray-dried redispersible granules (50-300μm) provide tablet mechanical strength of 80-150 N at only 3-8% binder content, significantly lower than conventional PVP solutions (10-20% w/w), while maintaining disintegration times of 3-8 minutes and >85% API release within 30 minutes.
DAI-ICHI KOGYO SEIYAKU CO. LTD./NIPPON SHOKUBAI CO. LTD.Pharmaceutical tablet binders requiring rapid dissolution kinetics, enhanced compressibility for direct compression processes, and improved surface area for immediate-release solid oral dosage forms.Powdery PVP (Spray-Dried Fine Granules)Two-fluid nozzle spray drying produces fine granular powder with ≥90% particles below 35μm diameter, average particle size under 20μm, enhanced surface area, and superior compressibility for direct compression tableting compared to conventional PVP powders.
Reference
  • Preparation of polyvinylpyrrolidone granules; method of granule production; and method of beverage treatment.
    PatentPendingCL202200295A1
    View detail
  • Slow-releasing granules and long acting mixed granules comprising the same
    PatentInactiveUS4971805A
    View detail
  • Preparation of low-dusting or non-dusting waterdispersible crosslinked polyvinylpyrrolidone granules
    PatentWO2021023726A1
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png